MedPath

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase 3
Completed
Conditions
Moderate to Severe Plaque Psoriasis
Interventions
Biological: ABT-874
Biological: etanercept
Drug: placebo
Registration Number
NCT00710580
Lead Sponsor
AbbVie (prior sponsor, Abbott)
Brief Summary

Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Diagnosis of Psoriasis for 6 MO
  • BSA 10%
  • PASI 12 or above
  • PGA 3 or above
Exclusion Criteria
  • Previous exposure to either etanercept or ABT-874

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AABT-874-
Betanercept-
Cplacebo-
Primary Outcome Measures
NameTimeMethod
Proportion of subjects who achieve a PGA of 0 or 1 response relative to baseline at Week 1212 Weeks
Proportion of subjects who achieve a PASI 75 response relative to baseline at Week 1212 Weeks
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects who achieve a PASI 100 response relative to baseline at Week 1212 Weeks

Trial Locations

Locations (42)

Site Reference ID/Investigator# 9981

🇺🇸

Dallas, Texas, United States

Site Reference ID/Investigator# 10502

🇺🇸

Little Rock, Arkansas, United States

Site Reference ID/Investigator# 10762

🇺🇸

Atlanta, Georgia, United States

Site Reference ID/Investigator# 10662

🇺🇸

Santa Monica, California, United States

Site Reference ID/Investigator# 10641

🇺🇸

St. Louis, Missouri, United States

Site Reference ID/Investigator# 15142

🇺🇸

Plainfield, Indiana, United States

Site Reference ID/Investigator# 9788

🇺🇸

Fort Gratiot, Michigan, United States

Site Reference ID/Investigator# 14701

🇺🇸

Los Angeles, California, United States

Site Reference ID/Investigator# 10661

🇺🇸

Irvine, California, United States

Site Reference ID/Investigator# 10501

🇺🇸

West Palm Beach, Florida, United States

Site Reference ID/Investigator# 10666

🇺🇸

Maywood, Illinois, United States

Site Reference ID/Investigator# 10241

🇺🇸

New York, New York, United States

Site Reference ID/Investigator# 10001

🇺🇸

Scottsdale, Arizona, United States

Site Reference ID/Investigator# 10504

🇺🇸

Dayton, Ohio, United States

Site Reference ID/Investigator# 10604

🇺🇸

Grand Blanc, Michigan, United States

Site Reference ID/Investigator# 10541

🇺🇸

Fridley, Minnesota, United States

Site Reference ID/Investigator# 15201

🇺🇸

Alpharetta, Georgia, United States

Site Reference ID/Investigator# 9901

🇺🇸

Miami, Florida, United States

Site Reference ID/Investigator# 9984

🇺🇸

Birmingham, Alabama, United States

Site Reference ID/Investigator# 10605

🇺🇸

Birmingham, Alabama, United States

Site Reference ID/Investigator# 9785

🇺🇸

San Diego, California, United States

Site Reference ID/Investigator# 10264

🇺🇸

San Antonio, Texas, United States

Site Reference ID/Investigator# 10182

🇺🇸

Seattle, Washington, United States

Site Reference ID/Investigator# 9790

🇺🇸

Owensboro, Kentucky, United States

Site Reference ID/Investigator# 10606

🇺🇸

Omaha, Nebraska, United States

Site Reference ID/Investigator# 10644

🇺🇸

Omaha, Nebraska, United States

Site Reference ID/Investigator# 10321

🇺🇸

Milwaukee, Wisconsin, United States

Site Reference ID/Investigator# 9985

🇺🇸

Bakersfield, California, United States

Site Reference ID/Investigator# 10503

🇺🇸

Jacksonville, Florida, United States

Site Reference ID/Investigator# 10642

🇺🇸

Vallejo, California, United States

Site Reference ID/Investigator# 9789

🇺🇸

Snellville, Georgia, United States

Site Reference ID/Investigator# 15750

🇺🇸

Owensboro, Kentucky, United States

Site Reference ID/Investigator# 9786

🇺🇸

Berlin, New Jersey, United States

Site Reference ID/Investigator# 9787

🇺🇸

Rochester, New York, United States

Site Reference ID/Investigator# 10581

🇺🇸

Wilmington, North Carolina, United States

Site Reference ID/Investigator# 9982

🇺🇸

Webster, Texas, United States

Site Reference ID/Investigator# 10643

🇺🇸

Knoxville, Tennessee, United States

Site Reference ID/Investigator# 9902

🇺🇸

Hickory, North Carolina, United States

Site Reference ID/Investigator# 10266

🇺🇸

Miami, Florida, United States

Site Reference ID/Investigator# 10263

🇺🇸

New Haven, Connecticut, United States

Site Reference ID/Investigator# 10265

🇺🇸

Louisville, Kentucky, United States

Site Reference ID/Investigator# 10262

🇺🇸

Newnan, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath